欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6379/001
药品名称Letybo 50 Einheiten Pulver zur Herstellung einer Injektionslösung
活性成分
    • Clostridium botulinum type A neurotoxin complex 50.0 U
剂型Powder for solution for injection
上市许可持有人Croma-Pharma GmbH Industriezeile 6 2100 Leobendorf Austria
参考成员国 - 产品名称Germany (DE)
Letybo 50 Einheiten Pulver zur Herstellung einer Injektionslösung
互认成员国 - 产品名称
    • Belgium (BE)
    • Slovakia (SK)
    • Iceland (IS)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Malta (MT)
      Letybo 50 units powder for solution for injection
    • Romania (RO)
    • Czechia (CZ)
      Letybo
    • Poland (PL)
      Letybo
    • Cyprus (CY)
      Letybo, 50 Croma units, powder for solution for injection
    • Italy (IT)
    • Croatia (HR)
    • Hungary (HU)
      Letybo 50 NE por oldatos injekcióhoz
    • Portugal (PT)
    • Slovenia (SI)
    • Finland (FI)
    • Spain (ES)
    • Bulgaria (BG)
      Letybo
    • Norway (NO)
    • France (FR)
    • Estonia (EE)
    • Sweden (SE)
    • Austria (AT)
    • Lithuania (LT)
      Letybo 50 vienetų milteliai injekciniam tirpalui
    • Greece (GR)
    • Ireland (IE)
    • Latvia (LV)
    • Luxembourg (LU)
    • Netherlands (NL)
    • Liechtenstein (LI)
许可日期2022/01/25
最近更新日期2024/10/02
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Other
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase